Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,600.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,188
  • Market Cap: £240.10m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (19-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 3.3% 0.0%
Div Cover 1.1 1.0
Op Mrgn 78.3% 80.0%
ROCE 83.0%  
Latest F'cast
P/E 28.6 27.7
PEG 3.2 8.0
Pr/Revenue 18.7 17.2
Pr/Book 19.9  
Latest F'cast
Revenue 9.4% 9.2%
PBT 9.2% 10.5%
EPS 9.0% 3.5%
DPS 20.6% 5.9%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 14.00 11.20 166.20p 27.7 8.0 +4% 161.00p 0.0%
30-Jun-25 15.10 12.10 179.30p 25.7 3.3 +8% 172.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Holding(s) in Company 12-Apr-2024 11:05 RNS
Interim Results 25-Mar-2024 07:00 RNS
Director/PDMR Shareholding 29-Jan-2024 15:15 RNS

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,600.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 1,188
Shares Issued 5.22m
Market Cap £240.10m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.55% below the market average98.55% below the market average98.55% below the market average98.55% below the market average98.55% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
85.44% above the market average85.44% above the market average85.44% above the market average85.44% above the market average85.44% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
28.98% below the market average28.98% below the market average28.98% below the market average28.98% below the market average28.98% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 19-Apr-2024

Time Volume / Share Price
16:12 35 @ 4,675.00p
15:43 5 @ 4,550.00p
15:33 50 @ 4,608.00p
14:58 250 @ 4,595.00p
14:57 13 @ 4,530.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page